Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. (Nasdaq: SY) is described as the leading aesthetic treatment platform in China, connecting consumers with online services and offline treatments. The news flow around SY focuses heavily on quarterly financial and operational updates, corporate actions related to its listing, and developments in its branded aesthetic center network and product activities.
Investors following SY news will see regular unaudited financial results releases furnished on Form 6-K, covering revenue composition across aesthetic treatment services, information and reservation services, sales of medical products and maintenance services, and other services. These announcements also provide detail on cost of revenues, operating expenses, non-GAAP metrics and cash positions, giving readers insight into how So-Young’s business mix is evolving over time.
Operational highlights in So-Young’s news include the number of fully operational branded aesthetic centers in major Chinese cities, verified treatment visits, verified aesthetic treatments performed and active users visiting the centers. The company also discloses information on the number of institutions served with supply chain solutions for injectables and shipment volumes for injectable products such as Elasty, illustrating activity in its upstream product and supply chain segment.
Corporate and capital market updates are another recurring theme in SY news. So-Young has issued press releases on plans and timing for ADS ratio changes, as well as notifications about regaining compliance with Nasdaq’s minimum bid price requirement. The company also announces the filing of its annual report on Form 20-F and provides schedules and dial-in details for earnings conference calls.
For readers and investors, the SY news page offers a centralized view of So-Young’s financial performance, operational metrics, listing-related developments and strategic updates. Monitoring these releases can help track how the company’s aesthetic treatment platform, branded centers and medical aesthetic product activities are progressing over time.
So-Young International Inc. (Nasdaq: SY) reported its unaudited financial results for Q2 2020, showing total revenues of RMB328.2 million (US$46.5 million), a 15.2% year-over-year increase. However, net income dropped significantly to RMB2.1 million (US$0.3 million) from RMB29.3 million in Q2 2019. Non-GAAP net income also fell to RMB30.1 million (US$4.3 million) from RMB102.2 million. The company saw a 173.7% surge in average mobile monthly active users to 6.8 million. Looking ahead, So-Young expects revenues between RMB340 million and RMB370 million for Q3 2020.
So-Young International Inc. (NASDAQ: SY) announced it will release its Q2 financial results on August 27, 2020, before U.S. markets open. An earnings conference call will follow at 7:30 AM ET, with preregistration required due to COVID-19. The company is recognized as the leading social platform in China's medical aesthetics sector, offering reliable content and community engagement. So-Young is well-positioned to grow within both its industry and the expanding healthcare market.
So-Young International reported Q1 2020 revenues of RMB182.6 million (US$25.8 million), exceeding guidance but down 11% YoY due to COVID-19's impact. Net loss stood at RMB35.9 million (US$5.1 million), contrasting with a profit of RMB45.9 million in Q1 2019. However, average mobile MAUs surged 116.8% YoY to 4.17 million, and the number of paying service providers increased 22%. Looking ahead, the company anticipates Q2 revenues between RMB320 million and RMB350 million, marking a potential 12.3% to 22.8% increase from 2019.
So-Young International Inc. (NASDAQ: SY) will report its Q1 financial results on May 18, 2020, before U.S. market opening. The company, a leading social community in China's medical aesthetics industry, will conduct a conference call at 7:30 AM ET on the same day. Due to COVID-19, preregistration is required for participants. The company is well-positioned for growth in the medical aesthetics and healthcare service markets, leveraging its strong brand and extensive audience.
Summary not available.
Summary not available.